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A Rab10:RalA G protein cascade regulates 
insulin-stimulated glucose uptake in adipocytes
Sheelarani Karunanithia, Tingting Xionga,b, Maeran Uhma,b, Dara Letoa, Jingxia Suna, 
Xiao-Wei Chena,b, and Alan R. Saltiela,b
aLife Sciences Institute and bDepartments of Internal Medicine and Molecular and Integrative Physiology, University of 
Michigan Medical School, Ann Arbor, MI 48109
ABSTRACT Insulin-stimulated glucose uptake in fat and muscle is mediated by the major fa-
cilitative glucose transporter Glut4. Insulin controls the trafficking of Glut4 to the plasma 
membrane via regulation of a series of small G proteins, including RalA and Rab10. We dem-
onstrate here that Rab10 is a bona fide target of the GTPase-activating protein AS160, which 
is inhibited after phosphorylation by the protein kinase Akt. Once activated, Rab10 can in-
crease the GTP binding of RalA by recruiting the Ral guanyl nucleotide exchange factor, Rlf/
Rgl2. Rab10 and RalA reside in the same pool of Glut4-storage vesicles in untreated cells, 
and, together with Rlf, they ensure maximal glucose transport. Overexpression of membrane-
tethered Rlf compensates for the loss of Rab10 in Glut4 translocation, suggesting that Rab10 
recruits Rlf to membrane compartments for RalA activation and that RalA is downstream of 
Rab10. Together these studies identify a new G protein cascade in the regulation of insulin-
stimulated Glut4 trafficking and glucose uptake.
INTRODUCTION
Insulin stimulates glucose uptake in adipocytes and skeletal muscle 
by promoting the translocation of the facilitative glucose transporter 
Glut4 to the plasma membrane (Pessin and Saltiel, 2000). In the 
basal state, Glut4 is contained in endosomes and postendosomal 
Glut4 storage vesicles (GSVs), which traffic to the cell surface in re-
sponse to insulin via a process that involves the activation of small G 
proteins (Leto and Saltiel, 2012). Although our understanding of the 
signaling cascades that govern these GTPases is incomplete, activa-
tion of the protein kinase Akt downstream of phosphoinositide 3-ki-
nase is known to be a key event (Whiteman et al., 2002; Hou and 
Pessin, 2007; Sakamoto and Holman, 2008). Several studies indicate 
that Akt can phosphorylate different GTPase-activating proteins, in 
the process reducing the inactivation of their cognate GTPases and 
thus producing increased G protein activity (Kane et al., 2002; Chen 
et al., 2011b).
One Akt substrate that has been implicated in regulating Glut4 
translocation is AS160 (Sano et al., 2003; Thong et al., 2007), which 
contains multiple Akt phosphorylation sites and a TBC1 domain with 
putative GTPase-activating protein (GAP) activity toward certain Rab 
GTPases (Kane et al., 2002). Small interfering RNA (siRNA)–medi-
ated depletion of AS160 in 3T3-L1 adipocytes increases basal Glut4 
translocation and glucose uptake, an effect that can be reversed by 
reintroducing the wild-type AS160, but not the GAP-deficient AS160 
RK mutant, suggesting that AS160 retains Glut4 in intracellular com-
partments in a GAP activity–dependent manner (Eguez et al., 2005; 
Larance et al., 2005). In vitro GTP hydrolysis assays revealed that 
AS160 can catalyze GTP hydrolysis of Rab2, Rab8A, Rab10, and 
Rab14 (Miinea et al., 2005). Among these, only Rab10 is required for 
insulin-stimulated Glut4 translocation in 3T3-L1 adipocytes (Sano 
et al., 2007, 2008). However, there is no direct evidence that any of 
these Rab GTPases are the functional targets of AS160 and whether 
phosphorylation of AS160 by Akt is related to Rab target activation.
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RalGAP domain that inactivates RalA. The 
complex also requires a regulatory protein, 
RGC1, which stabilizes RGC2. Akt2 phos-
phorylation of RGC2 leads to its inactiva-
tion, in the process producing increased 
GTP-bound RalA. RalA, in turn, resides in 
Glut4 vesicles and directs GSVs to the 
plasma membrane by interacting with 
Sec5 and Exo84 of the exocyst complex, 
an evolutionarily conserved, eight-subunit 
structure that assembles at the plasma 
membrane (Moskalenko et al., 2002; Chen 
et al., 2007, 2011a). After this interaction, 
phosphorylation of Sec5 by protein kinase C 
releases RalA from the exocyst, leading to 
disengagement of Glut4 vesicles, thus per-
mitting their fusion with the plasma mem-
brane (Chen et al., 2011a).
Although Rab10 and RalA are believed 
to be controlled mainly by inactivation of 
their cognate GAP proteins, the role of ex-
change factors in the hormonal regulation 
of their activities is not well understood. 
Moreover, the relative roles of these two G 
proteins and their relationship to each other 
in the Glut4 trafficking process remain un-
certain. In this study, we establish Rab10 as 
a functional target of AS160 and demon-
strate that the GAP activity of AS160 toward 
Rab10 is negatively regulated by Akt phos-
phorylation. We show that Rab10 and RalA 
are both required for insulin-stimulated glu-
cose uptake in 3T3-L1 adipocytes. We also 
investigate the relationship of Rab10 and 
RalA and reveal that Rab10 activity is re-
quired for, and lies upstream of, RalA in a 
crucial insulin signaling cascade, due to the 
recruitment by Rab10 of its effector, the Ral 
guanine nucleotide exchange factor (GEF) 
Rlf, leading to the activation of RalA. These 
findings establish the important role of a G 
protein cascade in the control of Glut4 
trafficking.
RESULTS
AS160 inhibits Rab10 activity
Previous studies demonstrated that GAP 
proteins preferentially interact with their 
cognate small GTPases during the transition 
state of GTP hydrolysis (Scheffzek et al., 
1997; Bos et al., 2007). To identify a cellular 
target of AS160, we loaded glutathione S-
transferase (GST)–Rab proteins with guano-
sine diphosphate (GDP)/AlF4 to mimic this 
transition state, incubating the fusion pro-
teins with lysates from COS-1 cells overex-
pressing FLAG-AS160. AS160 specifically interacted with GST-Rab10 
bound to GDP/AIFx but not with GST-Rab10 bound to GDP or 
GTPγS (Figure 1A), indicating that the interaction between AS160 
and Rab10 is transition state dependent. Meanwhile, AS160 did not 
interact, or interacted only modestly, with other GDP/AIFx-loaded 
small GTPases, including the Ras subfamily member RalA and the 
Another Akt substrate that has been invoked in insulin-stimulated 
glucose uptake is the RalA GAP complex RGC1/2 (Chen et al., 
2011b). This complex bears some homology to the tuberous sclero-
sis complex, which targets the G protein Rheb upstream of mTORC1 
activation by growth factors (Inoki et al., 2003; Shirakawa et al., 
2009). RGC2 has multiple Akt phosphorylation sites and contains a 
FIGURE 1: Rab10 is an in vivo target of AS160. (A–C) COS-1 cell lysates overexpressing 
FLAG-AS160 was incubated with immobilized GST or GST-Rab4, 5, 10, 11, or RalA bound to 
GDP, GTPγS, or GDP/AIFx as indicated. Pull downs were subjected to SDS–PAGE and Western 
blot with anti-FLAG antibody. GST proteins were visualized with Ponceau S. (D) COS-1 cells were 
transiently transfected with HA-Rab10 WT, QL, or TN constructs as indicated, and cell lysates 
were incubated with immobilized GST-Rim1-RBD. Pull downs were resolved on SDS–PAGE and 
visualized by Western blot with anti-HA antibody. (E) Quantification of Rab10 activity in D from 
three independent experiments. Rab10 activity was quantified by normalizing the amount of 
pull down with the total cell lysate. The value of the activity of wild-type Rab10 was then set as 1 
arbitrary unit. *p < 0.05. (F) 3T3-L1 adipocytes were transfected with FLAG-AS160 and 
HA-Rab10 (QL), and the activity of Rab10 was determined by GST-Rim1-RBD pull-down assay as 
described previously. (G) COS-1 cells were transiently transfected with HA-Rab10 alone or with 
FLAG-AS160 4A and/or Myr-Akt constructs as indicated. Cell lysates were subjected to 
GST-Rim1-RBD pull-down assay as described previously.
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binding domain (RBD) at its N-terminus 
(Fukuda, 2003). Lysates from COS-1 cells 
expressing wild-type, constitutively active 
(Q68L/QL), or a GDP-locked version (T23N/
TN) of Rab10 were subjected to the GST-
Rim1-RBD pull-down assay, validating the 
assay for activity of Rab10 (Figure 1, D and 
E). Similar interactions were detected by im-
munoprecipitation in which Myc-Rim1-RBD 
preferably formed a complex with the active 
mutant of Rab10 (QL) (Supplemental Figure 
S1B) and by pull-down experiments with 
GDP/GTPγS-loaded Rab10 in vitro (Supple-
mental Figure S1C). We then used the Rim1-
RBD pull-down assay to test whether AS160 
can inactivate Rab10 in vivo. As shown in 
Figure 1F, <40% of Rab10 was pulled down 
by GST-Rim1-RBD in the presence of over-
expressed AS160 in 3T3-L1 adipocytes, in-
dicating that AS160 can inactivate Rab10 in 
cells. AS160 phosphorylation was enhanced 
in COS-1 cells expressing constitutively ac-
tive Myr-Akt compared with control cells. 
Moreover, the inhibitory effect of AS160 on 
Rab10 activity in vivo was almost completely 
abolished by Myr-Akt phosphorylation (Sup-
plemental Figure S1, D and E). Furthermore, 
overexpression of the nonphosphorylable 
AS160 4A mutant, in which four (Ser-318, 
Ser-588, Thr-642, Ser-751) of the five Akt 
phosphorylation sites are mutated to ala-
nine (Sano et al., 2003), significantly inhib-
ited Rab10 activity. Myr-Akt expression did 
not influence the GAP activity of the non-
phosphorylable mutant (Figure 1G). To-
gether these data establish that Rab10 is a 
functional target of AS160 in vivo.
Rab10 functions upstream of RalA
Recent evidence on the sequential 
action of G proteins in vesicular trafficking 
(Mizuno-Yamasaki et al., 2012) suggests that 
G protein cascades could be a general 
mechanism in the regulation of vesicle recy-
cling. Of interest, upon insulin stimulation in 
fat cells, Akt1/2 phosphorylates and inacti-
vates both AS160 (Kane et al., 2002) and the 
RalGAP complex RGC1/2 (Chen et al., 
2011b), leading to the activation of Rab10 
and RalA. However, the relative roles of 
these G proteins and their relationship to 
each other remain unknown. Whereas the 
overexpression of constitutively active RalA 
(G23V/GV) or Rab10 (Q68L/QL) (Figure 2C) independently increased 
basal glucose uptake in adipocytes (Figure 2A), no additive effects 
were observed with co-overexpression of the two active G proteins 
in the same cells. Expression of active RalA modestly increased insu-
lin-stimulated glucose uptake, without further effect from coexpres-
sion of Rab10 (QL) (Figure 2B). These data suggest the possibility 
that RalA and Rab10 might reside in a linear pathway, and we thus 
determined whether either of the two G proteins might influence 
the activity of the other. Although overexpression of constitutively 
Rab subfamily members Rab4, Rab5, and Rab11 (Figure 1, B and C). 
These results suggest that the transition state–dependent binding 
between AS160 and Rab10 is specific and characteristic of a GAP-
substrate GTPase interaction, consistent with the notion that AS160 
possesses GAP activity toward Rab10 in vitro.
To test whether AS160 can catalytically inactivate Rab10 in vivo, 
we developed an effector pull-down assay to evaluate the activation 
state of Rab10 (Supplemental Figure S1A). Rab3-interacting mole-
cule 1 (Rim1) was reported to interact with Rab10 through the Rab-
FIGURE 2: Rab10 activates RalA. (A) 3T3-L1 adipocytes expressing the indicated active G 
proteins using lentiviral vectors were subjected to 2-deoxyglucose uptake assay. Glucose uptake 
under basal conditions are shown. *p < 0.05; **p < 0.01. (B) Glucose uptake under conditions in 
A upon insulin stimulation. (C) Level of indicated proteins in 3T3-L1 adipocytes under conditions 
in A and B were assessed by immunoblots. (D) 3T3-L1 adipocytes were electroporated with 
50 μg of the indicated plasmids. Two days after electroporation, cells were starved for 16 h and 
treated with 10 nM insulin for 5 min, and pull-down assay was performed using GST-Sec5-RBD 
beads. (E) Immunoblots from three independent experiments as in D were quantified using 
ImageJ (National Institutes of Health, Bethesda, MD) and graphed. *p < 0.05. (F) Indicated 
plasmids were expressed in Cos-1 cells, and cells were lysed after 24 h. Pull down with GST-
RalBP1 beads was performed, and samples were run on SDS–PAGE and immunoblotted. 
(G) RalA activity as measured by quantification of three independent experiments as in F. 
Statistical tests were performed by comparing each condition to that of the vector. *p < 0.01.
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that Rab10 functions upstream of RalA, and 
further that its activation can stimulate RalA 
activity.
Rab10 activates RalA through Rlf
The activation of RalA by Rab10 could be 
due to inactivation of the RalGAP complex, 
activation of a RalGEF, or both. RGC1/2 is 
inactivated upon insulin stimulation through 
Akt phosphorylation of the catalytic sub-
unit RGC2 (Chen et al., 2011b). Rab10 
overexpression did not accelerate or affect 
the phosphorylation status of RGC2 
(unpublished data). Moreover, a point mu-
tation in RalA (F39L/FL) with increased 
nucleotide dissociation rates that quickly 
cycles between GDP and GTP (Reinstein 
et al., 1991; Lim et al., 2005), and thus does 
not require a GEF for activation, was not 
influenced by overexpression of Rab10 
(QL), unlike what was observed for RalA 
(wild type [WT]; Figure 3A).
Together these data suggest that Rab10 
might activate RalA through recruitment or 
activation of a specific GEF. There are sev-
eral known GEFs for RalA, including Rgl1, 
Rgl2/Rlf, Rgl3, RalGDS, and others (Neel 
et al., 2011). Among these, Rlf, the mouse 
homologue of Rgl2, is most abundant in 
3T3-L1 adipocytes (unpublished data). To 
evaluate the role of Rlf in Rab10-stimulated 
RalA activation, we knocked down Rlf in 
293T cells, since this cell line has high basal 
Akt phosphorylation and as a result reduced 
RalGAP activity. Knockdown of Rlf decreased 
basal RalA activity. Whereas overexpression 
of Rab10 (QL) caused a twofold increase in 
RalA activity, depletion of Rlf blocked this ef-
fect (Figure 3, B and C). We also introduced 
Rab10 (QL) in the presence of ectopic ex-
pression of hemagglutinin (HA)-Rlf. Whereas 
Rab10 (QL) and Rlf increased RalA activity 
independently, coexpression of the two pro-
teins was synergistic (Figure 3D), suggesting 
the possibility that Rab10 can recruit Rlf to 
activate RalA.
Rlf is an effector of Rab10
Because Rlf is required for Rab10-stimulated 
activation of RalA, we tested whether Rlf 
might be a direct effector for Rab10. Immu-
noprecipitation of HA-Rlf from Cos-1 cells 
overexpressing Myc-Rab10 (WT or QL) re-
vealed that Rab10 specifically binds to Rlf, 
and further that this binding depends on the activation state of 
Rab10 (Figure 4A). Constitutively active Rab10 (QL) was twofold 
more effective in binding to Rlf than with the wild-type G protein 
(Figure 4C). Rlf binding to Rab10 (QL) was comparable to that ob-
served with Rim1-RBD, a known effector of Rab10 (Figure 4, B and 
4C). In addition, reciprocal immunoprecipitation of Myc-Rab10 also 
showed specific binding of Rlf to active Rab10 (QL) (Supplemental 
Figure S3).
active RalA did not alter cellular Rab10 activity, measured as de-
scribed (Supplemental Figure S2), Rab10 overexpression produced 
an increase in RalA activity under insulin-stimulated conditions 
(Figure 2, D and E) as measured by GST-Sec5-RBD pull-down assay. 
Activation of RalA was dependent on the activation status of Rab10. 
Overexpression of the constitutively active Rab10 (QL) allele caused 
hyperactivation of RalA, whereas a GDP-locked version of Rab10 
(TN) decreased RalA activity (Figure 2, F and G). These data suggest 
FIGURE 3: Rab10 activates RalA through Rlf. (A) Rab10 activates RalA through a GEF. Wild-type 
and F39L mutant of RalA were expressed with or without HA-Rab10 in Cos-1 cells. Pull-down 
assay was performed with GST-RalBP1 beads, and samples were run on SDS–PAGE and Western 
blotted. (B) Stealth siRNA knockdown of Rlf in 293T cells. Two days posttransfection, cells were 
lysed, and RalA pull down with GST-RalBP1 beads was performed. Levels of indicated proteins in 
total cell lysates and pull down are shown. (C) Images from experiment in B were quantified by 
ImageJ and plotted. *p = 0.05. (D) Cos-1 cells were transfected with FLAG-RalA together with 
Myc-Rab10 (QL), HA-Rlf, or both. At 24 h later, cells were lysed and subjected to pull-down 
assay using GST-Sec5-RBD beads. Lysates and pull-down samples were run on SDS–PAGE and 
immunoblotted.
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tion (RA) domain of the latter protein (Figure 4D) and functions in 
cellular transformation (Wolthuis et al., 1997). Using a version of Rlf 
that contained only the RA domain (amino acids 543–778; Wolthuis 
Together these data suggested that Rlf could be a downstream 
effector of Rab10. Rlf is a known effector of another small G protein, 
Ras; constitutively active Ras (RasV12) binds to Rlf in the Ras activa-
FIGURE 4: Rab10 interacts with Rlf. (A) Indicated proteins were ectopically expressed in Cos-1 cells. 
Immunoprecipitation with HA-Rlf shows specific interaction with Rab10 in immunoblots. (B) Cos-1 cells were transfected 
with indicated plasmids. At 24 h later, cells were lysed and immunoprecipitated with antibodies against Myc. Level of 
proteins in the total cell lysate and the immunoprecipitates are shown. (C) Quantification of blots in A and B. Images 
from three independent experiments were used to generate error bars. *p < 0.05. (D) Schematic representation of 
various domains in full-length and truncated Rlf. (E) Pull-down assay with GST-Rlf-RA. Indicated plasmids were expressed 
in Cos-1 cells, and GST or GST-Rlf-RA beads were used for pull down. Specific and increased binding to Rab10 (QL) are 
shown. (F) Lysates from Cos-1 cells expressing HA-Rab10 were treated with 1.0 mM GDP or 0.5 mM GTPγS. Pull-down 
experiments were performed with indicated GST beads. Protein levels in the total cell lysate, as well as pull down, are 
shown. (G) Pull-down experiment was performed as in F, except that GST-Rlf-RA beads were used instead of full-length 
Rlf. (H) Quantification of blots in F and G. Binding of Rim1 to GDP-bound Rab10 was set to 1, and fold changes in 
binding of Rlf and Rlf-RA to Rab10 in GDP/GTP-bound states were calculated. Error bars were acquired from at least 
three independent experiments. **p < 0.01, *p < 0.05.
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et al., 1996), we pulled down HA-Rab10 
overexpressed in Cos-1 cells (Figure 4E). To 
further confirm that this binding is depen-
dent on the activation status of Rab10, we 
performed a pull-down assay using lysates 
from Cos-1 cells overexpressing HA-Rab10 
after in vitro addition of GDP or nonhydro-
lyzable GTP (GTPγS). This assay demon-
strated that upon binding to GTPγS, Rab10 
interacted with a Rim1-RBD fusion protein 
significantly better than did Rab10-GDP 
(Figure 4, F and H). Similarly, both the full-
length and RA domain of Rlf were equally 
effective in specifically binding to Rab10-
GTPγS (Figure 4, F–H). These data indicate 
that Rlf is a downstream effector of Rab10 
and that the RA domain of Rlf is sufficient to 
interact with Rab10, as is the case for its in-
teraction with Ras (Peterson et al., 1996; 
Wolthuis et al., 1996).
Rab10, RalA, and Rlf are required 
for insulin-stimulated glucose uptake 
in 3T3-L1 adipocytes
Rab10 and RalA are established compo-
nents of the insulin regulatory network and 
are required for Glut4 translocation and glu-
cose uptake in adipocytes (Chen et al., 
2007; Sano et al., 2007, 2008). Because Rlf 
appears to be an intermediate in this activa-
tion cascade, we hypothesized that the GEF 
may also be essential. We depleted Rlf us-
ing siRNA in 3T3-L1 adipocytes before as-
saying 2-deoxyglucose uptake. The expres-
sion of Rlf was reduced by ∼70% after 
incubation with siRNA oligos (Figure 5B). 
Knockdown of Rlf caused a 15–20% loss in 
insulin-stimulated glucose uptake, compa-
rable to the effect achieved by knockdown 
of RalA (Chen et al., 2007) and Rab10 (Figure 
5A). Because RalA and Rab10 are required 
for translocation of Glut4 storage vesicles to 
the plasma membrane upon insulin stimula-
tion (Chen et al., 2007; Sano et al., 2007), 
we also tested the effect of Rlf knockdown 
on Glut4 translocation. Knockdown of Rlf in 
3T3-L1 adipocytes stably expressing Myc-
Glut4–enhanced green fluorescent protein 
(eGFP; Bogan et al., 2001; Lodhi et al., 2007) 
caused a significant reduction (∼25%) in sur-
face Glut4 levels similar to the effect of 
knockdown of RalA and Rab10 (Figure 5, 
C–E). Together these data suggest that Rlf 
is a new component required for Glut4 
translocation and is essential for maximal 
glucose uptake in adipocytes.
Rab10 affects RalA activity through 
Rlf in adipocytes
As we showed, active Rab10 increases RalA 
activity through Rlf (Figure 3, B–D). Because 
Rab10 can increase RalA activity via recruit-
ment of Rlf (Figures 3 and 4), we attempted 
FIGURE 5: Rlf is required for maximal glucose uptake in 3T3-L1 adipocytes. (A) siRNA-mediated 
depletion of indicated genes in 3T3-L1 adipocytes. Six days after knockdown, cells were starved, 
and 2-deoxyglucose uptake was measured. A representative assay from five independent 
repetitions is shown. *p < 0.05, **p < 0.01. (B) Knockdown efficiency and insulin signaling in 
conditions in A. (C) Glut4 translocation assay. 3T3-L1 adipocytes stably expressing Myc-Glut4-
eGFP were used for knockdown of indicated genes. Scrambled siRNA was used as control. 
Immunostaining for Myc (red) in nonpermeabilized cells indicates Glut4 translocation to plasma 
membrane. GFP levels in cells indicate total Glut4 expressed. A merge of GFP and Myc is 
shown. Bar, 10 μm. (D) Number of cells that show Myc staining at the rim in the total number of 
GFP-positive cells was counted for control and Rab10 and Rlf knockdown. Percentage of cells 
that undergo Glut4 translocation is graphed. Error bars are indicative of at least three 
independent experiments. *p < 0.05. (E) Knockdown efficiency at protein level is shown by 
immunoblots. Intact insulin signaling under conditions in D is shown by Western blotting.
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mental Figure S4A). Overexpression of Rlf-CAAX also produced a 
larger increase in RalA activity compared with the wild-type Rlf (Sup-
plemental Figure S4B; Wolthuis et al., 1997). Whereas Rab10 knock-
down caused a 25–30% loss in surface Glut4 levels (Figure 6, A and 
B), overexpression of Rlf-CAAX in these cells (Figure 6C) brought the 
surface Glut4 levels closer to that seen in control insulin-stimulated 
to rescue the effect of Rab10 knockdown by expression of an acti-
vated version of Rlf. We used a tagged version of Rlf (Rlf-CAAX) 
through addition of a CAAX motif to its C-terminus, thus tethering 
the protein to membranous compartments (Vigil et al., 2010). We 
confirmed that Rlf-CAAX partitioned more in the membrane fraction 
than in the cytosolic fraction, unlike the wild-type protein (Supple-
FIGURE 6: Rab10 acts on RalA through Rlf in 3T3-L1 adipocytes. (A) 3T3-L1 adipocytes stably expressing Myc-Glut4-
eGFP were electroporated with scrambled or Rab10 siRNA with or without FLAG-Rlf-CAAX. Two days later, cells were 
starved and treated with or without 10 nM insulin for 15 min. Nonpermeabilized cells were fixed and immunostained 
with anti-Myc antibodies. GFP indicates total Glut4 levels, and Myc staining in the rim (blue) represents presence or 
absence of Glut4 at the plasma membrane. Bar, 10 μm. (B) Percentage of cells that show Glut4 translocation upon 
insulin stimulation under various conditions in A was calculated by counting at least 100 cells in three independent 
experiments. *p < 0.05. (C) Knockdown efficiency and level of ectopically expressed FLAG-Rlf-CAAX in A are shown 
using Western blots. Insulin signaling was unaffected as detected by immunoblotting for pAkt (S473).
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in the plasma membrane fractions upon in-
sulin stimulation, with a concurrent loss of 
these proteins in the low-density microsome 
(LDM) fractions. Of interest, Rab10 localiza-
tion mirrored that of RalA (Figure 7A).
These data suggest that RalA and Rab10 
might be found together in some insulin-
responsive Glut4 vesicles. LDM fractions 
were thus further fractionated on an iodix-
anol density gradient to distinguish the insu-
lin-responsive Glut4 vesicles (peak 1) from 
the recycling endosomal fractions (peak 2; 
Hashiramoto and James, 2000). Optiprep 
fractions corresponding to insulin-respon-
sive GSVs (peak 1) contained Glut4 and 
IRAP as well as RalA and Rab10 (Figure 7B). 
The appearance of RalA and Rab10 peaks in 
fraction 10, but less so in fraction 9, which is 
enriched in Glut4 and IRAP, indicates that 
these small G proteins are associated with 
only a subpopulation of the insulin-sensitive 
Glut4 vesicles. Taken together, our studies 
show that Rab10 recruits Rlf to activate RalA, 
which plays a role in the translocation of 
Glut4 to the plasma membrane (Figure 7C).
DISCUSSION
Studies indicated that Rab10 may be a cru-
cial target of the GAP protein AS160 (Sano 
et al., 2007). Although data presented here 
confirm that Rab10 is indeed a target of 
AS160 in adipocytes, the molecular events 
that occur as a consequence of changes in 
Rab10 activity, and how they in turn contrib-
ute to the control of Glut4 trafficking, have 
remained a mystery. We reveal here the first 
novel effector for Rab10 in adipocytes, the 
guanyl nucleotide exchange factor Rlf, and 
demonstrate its role as an intermediate in a 
G protein cascade that mediates insulin-
stimulated glucose transport. We show that 
Rab10 is upstream of RalA and plays an im-
portant role in RalA activation by insulin, 
leading to its interaction with the exocyst. 
Furthermore, this activation cascade is re-
quired for insulin-stimulated glucose trans-
port and Glut4 translocation to the plasma 
membrane.
Many studies illustrated the importance of G protein activation 
cascades in control of vesicular trafficking in both mammalian and 
yeast cells, including TC10 to Rab5 (Lodhi et al., 2008), Rab11 to 
Rab8 (Bryant et al., 2010; Knodler et al., 2010), Rab5 to Rab7 (Bot-
tanelli et al., 2012), Ras to RalA (Wolthuis et al., 1997), and others 
(Hutagalung and Novick, 2011; Mizuno-Yamasaki et al., 2012). A key 
feature of such cascades is the colocalization of the relevant G pro-
teins. In this scenario, the G proteins are at least transiently found in 
the same population of vesicles, and the upstream protein recruits a 
GEF for activation of the downstream G protein. We show here that 
Rab10 and RalA are found in the same insulin-sensitive vesicle pool, 
and the cross-talk between them appears to be mediated by the 
RalA GEF, Rlf. Moreover, whereas Rab10, RalA, and Rlf are all re-
quired for full insulin-stimulated Glut4 translocation and glucose 
cells (Figure 6B). These data indicate that Rab10 affects Glut4 trans-
location at least partly by recruiting Rlf to activate RalA.
Rab10 and RalA function in the same subcellular 
compartment
The foregoing results suggest that Rab10 might coexist in the same 
cellular compartment as RalA. Furthermore, ectopic expression of a 
version of AS160 that is enriched at sites of Rab10 action through a 
C-terminal Rab10 membrane attachment motif (AS160GAP-Rab10 
tail) decreased RalA activity (Supplemental Figure S4C), indicating a 
localized effect of Rab10 on RalA.
We performed subcellular fractionation of 3T3-L1 adipocytes to 
assess the insulin-dependent changes in the cellular localization of 
RalA and Rab10. As expected, Glut4, IRAP, and RalA were enriched 
FIGURE 7: Rab10 and RalA reside in insulin-sensitive GSVs. (A) Subcellular fractionation of 
3T3-L1 adipocytes. Indicated fractions were run on SDS–PAGE and immunoblotted with 
antibodies as specified. HDM, high-density microsomes; LDM, low-density microsomes; N/M, 
nuclear/mitochondrial; PM, plasma membrane. L.E and D.E. denote light and dark exposures of 
the RalA blot, respectively. (B) LDM fractions from several independent experiments as in A 
were pooled to obtain an enriched fraction, which was then run on 14% iodixanol gradient. 
Fractions 1–11 represent lighter to denser peaks in the gradient. Insulin-sensitive pool of GSVs 
(fractions 8–10) is indicated by a box (peak 1). Peak 2 represents the second-less-responsive 
recycling endosomes, containing Glut4 (fractions 2–4). (C) Proposed model for the role of Rab10 
in Glut4 translocation. Rab10 recruits Rlf to insulin-sensitive GSVs to promote GEF activity on 
RalA. Activated RalA allows Glut4 translocation through its interactions with the myosin motor 
and the exocyst.
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(residues 11–399) was cloned from Marathon-Ready adult brain 
cDNA (Clontech, Mountain View, CA) by PCR and subcloned into 
pKCmyc (myc tag) vector and pGEX (GST tag) vector. Rab5 and 
RalA cDNA were obtained as described (Chen et al., 2007; Lodhi 
et al., 2007). Both were subcloned into pGEX vector. The Myr-Akt 
construct was kindly provided by Anne Vojtek (University of Michi-
gan, Ann Arbor, MI). To make the AS160GAP-Rab10tail chimera, the 
GAP domain of AS160 was amplified by PCR with a 3′ primer con-
taining the last 132 base pairs of Rab10 cDNA and subcloned into 
the red fluorescent protein (RFP) vector, which was kindly provided 
by Roger Tsien (University of California, San Diego, La Jolla, CA). 
Full-length Rlf and Rlf-RA (amino acids 543–778) were subcloned 
from HA-Rlf (Chen et al., 2011a) into pGEX4T1 vector (GE Health-
care, Piscataway, NJ). pBABE-HAII-Rlf-CAAX was described previ-
ously (McFall et al., 2001) and purchased from Addgene, Cam-
bridge, MA (plasmid 12592). Rlf and Rlf-CAAX were subcloned into 
pKFLAG and pCS2-MT vectors. All constructs were verified by se-
quencing at the University of Michigan DNA sequencing core.
GST-RalBP1 beads were purchased from EMD Millipore 
(Billerica, MA). Purification of GST-Sec5-Ral binding domain has 
been previously described (Chen et al., 2011a). Purification of 
Rim1-RBD using high-performance Glutathione Sepharose Beads 
was carried out according to the manufacturer’s instructions (GE 
Healthcare). GST-Rlf and GST-Rlf-RA were expressed in Rosetta 
(DE3 pLysS) cells (EMD Millipore, Billerica, MA), and purification 
protocol was adapted from Wolthuis et al. (1997). GST alone or 
GST-Rim1 RBD, RalA, Rab4, 5, 10, and 11 were expressed in 
BL21(DE3)pLysS Escherichia coli strain and purified as described 
(Smith and Johnson, 1988).
GDP-AIFx loading assay
GST alone or GST-fusion proteins bound to glutathione beads 
were incubated for 30 min at 25°C in loading buffer (20 mM Tris, 
pH 7.5, 1 mM dithiothreitol [DTT], 50 mM NaCl) with 2 mM EDTA 
and Complete, EDTA-free protease inhibitor tablets (Roche, San 
Francisco, CA). GST-Rab10 was then loaded with nucleotide by 
incubating in loading buffer supplemented with 2 mM GDP or 
200 mM GTPγS for 1 h at 25°C. To stop loading, 10 mM MgCl2 was 
added for 5 min at 25°C. To produce GDP/AlF4-bound Rab10, 
30 mM AlCl3 and 10 mM NaF were included in the GDP loading 
buffer. Loaded GST-Rab10 beads were then added to COS-1 cells 
that were lysed in buffer (25 mM Tris, pH 7.5, 137 mM NaCl, 10% 
glycerol, 1% NP-40, 5 mM MgCl2, and 1 mM DTT) supplemented 
with 10 μM GDP, 10 μM GTPγS, or 10 μM GDP, 30 μM AlCl3, and 
10 mM NaF, and Complete, EDTA-free protease inhibitor tablets. 
The reaction was incubated for 2 h at 4°C, and then beads were 
washed three times in wash buffer (25 mM Tris, pH 7.5, 40 mM 
NaCl, 30 mM MgCl2, 1% NP-40, and 1 mM DTT) and once in rinse 
buffer (25 mM Tris, pH 7.5, 40 mM NaCl, 30 mM MgCl2, and 1 mM 
DTT) supplemented with 10 μM GDP, 10 μM GTPγS, or 10 μM GDP, 
30 mM AlCl3, and 10 mM NaF, and Complete EDTA-free protease 
inhibitor tablets. The pull downs were solubilized in 2× SDS sample 
buffer and subjected to SDS–PAGE, and Western blotting was per-
formed using the indicated antibodies.
Statistical analysis
All error bars are depicted as SEM. Statistical significance was deter-
mined via Student’s t test.
Pull-down and coimmunoprecipitation experiments
Rab10-GTP was pulled down using GST-Rim1-RBD beads as a 
measure of active Rab10. GST-RalBP1 or GST-Sec5-RBD beads 
transport, expression of a membrane-tagged Rlf can rescue cells in 
which Rab10 has been depleted, strongly suggesting that it is the 
localization of the exchange factor that leads to RalA activation. This 
finding is particularly interesting in light of previous studies indicat-
ing that Rab10 may be upstream of the exocyst in certain instances 
(Jiang et al., 2008).
Although these studies provide the first hint of a relevant effector 
for Rab10 in the regulation of glucose uptake, several questions re-
main, including the relative roles of GEFs and GAPs in the regulation 
of these two G proteins. Both AS160 and RGC are specific GAPs for 
their cognate G proteins and are coordinately regulated by Akt-
catalyzed phosphorylation, leading to inactivation of the GAPs and 
subsequent increased activity of the G proteins (Sano et al., 2003; 
Chen et al., 2011b). However, blockade of GAP activity alone is not 
expected to produce G protein activation, since there must be a 
mechanism to increase GTP binding once GDP is bound to the pro-
tein. This insight, plus the data presented here, suggests that RalA 
activation requires negative regulation of the GAP and positive reg-
ulation of its GEF. Previous studies suggest a similar scenario for 
Rab10 via its GEF Dennd4C (Sano et al., 2011).
Although numerous studies demonstrated that G proteins play 
important roles in vesicle trafficking, it is also known that their activa-
tion must be transient, so that vesicles can move into the next com-
partment (Mizuno-Yamasaki et al., 2012). However, if their GAPs are 
used for G protein activation, how are the signals terminated? One 
solution to this perplexing question might lie in changes to their ef-
fectors. Our previous studies indicated that the RalA effector Sec5 
undergoes phosphorylation in adipocytes to permit the release of 
the Glut4 vesicle from the exocyst, thus permitting fusion with the 
plasma membrane (Chen et al., 2011a). One possibility is that Rlf 
undergoes a similar modification, ensuring that RalA is not constitu-
tively activated. These and other possibilities are under 
investigation.
MATERIALS AND METHODS
Cell culture and transfections
COS-1 cells and 293T cells were cultured in DMEM containing 10% 
fetal bovine serum (FBS). Transfections were carried out using Lipo-
fectamine 2000 following the manufacturer’s protocol (Life Technol-
ogies, Grand Island, NY). For overexpression experiments, cells 
were collected 18–24 h after transfection. Knockdown experiments 
in 293T cells were conducted for 48 h from the time of transfection. 
3T3-L1 preadipocytes were differentiated into mature adipocytes as 
described before (Liu et al., 2005). Electroporation into mature adi-
pocytes was done within 1–3 d postdifferentiation at 160 kV, 950 μF 
(Inoue et al., 2006). Knockdown was continued for 4–6 d after elec-
troporation unless specified otherwise. Viral work was carried out as 
described previously (Chen et al., 2011a). 3T3-L1 preadipocytes sta-
bly expressing Myc-Glut4-eGFP were maintained and differentiated 
as described previously (Lodhi et al., 2007). Cells were starved in 
reduced serum (0.5% FBS) medium for 16 h except indicated. Con-
centration of insulin used was 10 nM for specified times, unless 
stated otherwise.
Plasmids, siRNAs, and purification
Stealth siRNAs were purchased from Life Technologies, and oligo 
sequences are listed in the Supplemental Materials. Rab10 was sub-
cloned into pKH3 and pRK5-Myc vectors. Site-Directed Mutagene-
sis (QuikChange; Agilent Technologies, Santa Clara, CA) was used 
to generate active (Q68L) and inactive (T23N) mutants of Rab10. 
FLAG-RalA constructs (wild type, G23V, S28N, F39L) have been 
described before (Chen et al., 2007). The N-terminal RBD of Rim1 
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were used interchangeably to quantify RalA activity. Pull-down 
experiments were carried out in a buffer containing 100 mM Tris, 
pH 7.5, 10% glycerol, 1% NP-40, 1 mM DTT, 129 mM NaCl, 10 mM 
NaF, and 5 mM MgCl2 with protease inhibitor tablet (Roche) for 
40 min at 4°C. Proteins were extracted from beads in SDS-sample 
buffer and analyzed. Immunoprecipitation experiments were car-
ried out with indicated antibodies in a lysis buffer containing 
100 mM Tris, pH 7.5, 129 mM NaCl, 1% Triton X-100, 10 mM NaF, 
5 mM MgCl2, 1 mM EDTA, and 1 mM NaVO3 with protease inhibi-
tor tablet for 2 h to overnight at 4°C. Immunoprecipitates were ad-
sorbed on Protein A/G plus agarose (Santa Cruz Biotechnology, 
Dallas, TX) for 1 h, washed three times in lysis buffer, and eluted in 
2× SDS-sample buffer.
Reagents, antibodies, and immunoblotting
Samples were run on 4–20% precast SDS–PAGE gels (Novex, Life 
Technologies) and transferred to nitrocellulose membrane. Antibod-
ies to HA and Myc (monoclonal mouse and polyclonal rabbit) and 
human Rlf were purchased from Santa Cruz Biotechnology. Mouse-
FLAG antibodies were from Agilent Technologies. Anti-RFP anti-
bodies were from Abcam (Cambridge, MA). AS160 and pAS160 
(T642) antibodies were from EMD Millipore. Rabbit anti-Rlf serum 
described previously (Wolthuis et al., 1997) was affinity purified 
(Pacific Immunologies, Ramona, CA) and used for immunoblotting. 
RalA and caveolin3 antibodies were from BD Biosciences (San Jose, 
CA). Transferrin receptor antibody was from Zymed Labs. Glut4 
and Sec8 antibodies were purchased from Alpha Diagnostics (San 
Antonio, TX) and Enzo LifeSciences (Farmingdale, NY). Rab10, Akt, 
pAkt (S473), pAkt-substrate, histone H3, and IRAP antibodies were 
from Cell Signaling (Danvers, MA). Horseradish peroxidase–conju-
gated secondary antibodies were obtained from Thermo Scientific 
(Waltham, MA), and Alexa Flour secondary antibodies were from 
Molecular Probes, Life Technologies. Insulin, GDP, GTPγS, and 
Optiprep gradient solution were purchased from Sigma-Aldrich 
(St. Louis, MO).
Glucose uptake assay
The 2-deoxyglucose uptake assay was performed as previously de-
scribed (Inoue et al., 2006). Briefly, adipocytes that are 7–10 d post-
differentiation were starved for 6 h and treated with 10 nM insulin for 
30 min. The 14C-labeled glucose incorporation in 5 min was mea-
sured to calculate glucose uptake by 3T3-L1 adipocytes.
Glut4 translocation assay
Glut4 translocation in response to 10 nM insulin treatment for 
15 min was measured as described before (Inoue et al., 2006). Dif-
ferentiated adipocytes stably expressing Myc-Glut4-eGFP were 
used 4–6 d after knockdown except when proteins were overex-
pressed, during which cells were analyzed after 2 d. Immunostaining 
was performed using indicated antibodies. Glut4 translocation to 
the plasma membrane was measured by staining with Myc antibod-
ies in nonpermeabilized cells. Percentage of cells with insulin-stimu-
lated Glut4 translocation was calculated as the percentage of cells 
with Myc staining in the GFP-positive pool.
Subcellular fractionation and iodixanol gradient
3T3-L1 adipocytes that were 9–10 d postdifferentiation were lysed 
in HES buffer (20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid, pH 7.5, 1 mM EDTA, 250 mM sucrose) and homogenized in a 
Dounce homogenizer. Fractionation was performed by ultracentrifu-
gation using established protocols (Hashiramoto and James, 2000; 
Chen et al., 2007). LDMs were further fractionated on a 14% iodix-
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